| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $42,397,378 ) (Continued on the next page) |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30DE033587 | Evaluation of Trigeminal Ganglia Sensory Neuronal Population/s Mediating MIF-Induced Anti-Nociception in a Model of Apical Periodontitis. | 001 | 3 | NIH | 12/10/2025 | $53,721 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R13DA029347 | Behavior, Biology, and Chemistry: Translational Research in Substance Use Disorders | 000 | 16 | NIH | 2/19/2026 | $25,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 001 | 20 | NIH | 2/12/2026 | $619,849 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM128731 | Structure and Function of the Essential Cell Cycle Regulator Cdc34 | 000 | 9 | NIH | 2/12/2026 | $319,302 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R13AG099734 | Leveraging the Trusted Role of Churches to Disseminate Research, Resources, and Support to Communities Disproportionately Affected by Dementia | 000 | 1 | NIH | 2/19/2026 | $50,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM147636 | The role of EWSR1 at the centromere | 000 | 4 | NIH | 2/11/2026 | $310,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK128247 | The Regulation of Hepatic Metabolic Zonation by the Diabetes Gene TCF7L2 | 000 | 5 | NIH | 12/18/2025 | $489,396 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01EY012085 | Intercellular Communication in the Eye Lens | 000 | 28 | NIH | 12/10/2025 | $453,947 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 003 | 2 | NIH | 2/19/2026 | $267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 002 | 2 | NIH | 2/18/2026 | $338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01GM141631 | Repair of DNA ends with adducts | 000 | 4 | NIH | 2/9/2026 | $310,000 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI185790 | Lymphotoxin-dependent control of long COVID | 000 | 1 | NIH | 2/13/2026 | $234,715 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 000 | 5 | NIH | 1/30/2026 | $540,875 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R03AG086958 | Pathological cardiolipin remodeling links mitochondrial dysfunction to inflammaging | 001 | 2 | NIH | 2/2/2026 | $7,875 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 000 | 2 | NIH | 2/13/2026 | $3,267,462 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AG087698 | Development and evaluation of neuroimaging biomarkers of structural and functional network degeneration in Alzheimer’s disease | 001 | 2 | NIH | 3/31/2026 | $40,452 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK129676 | Targeting hepatic mitochondrial function in humans with NAFLD using insulin sensitizers | 000 | 5 | NIH | 3/23/2026 | $682,149 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA299621 | Development of first-in-class AAK1 PROTACs for ovarian cancer | 000 | 1 | NIH | 3/25/2026 | $593,338 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK097554 | Comparative Effectiveness of Two Initial Combination Therapies in Patients with New Onset Diabetes | 000 | 13 | NIH | 3/24/2026 | $684,914 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 002 | 2 | NIH | 3/25/2026 | $274,600 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R35GM127006 | Double strand break repair maelstrom: causes, mechanisms and genome destabilizing consequences | 000 | 9 | NIH | 4/3/2026 | $458,325 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA300241 | Targeting mucin-type O-glycosylation for EGFR mutant non-small cell lung cancer | 000 | 1 | NIH | 3/27/2026 | $609,846 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | U01AI182210 | An oral vaccine against Chlamydia trachomatis | 000 | 3 | NIH | 4/3/2026 | $2,150,524 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AG087361 | Investigating the Impact of Novel Senescent Microglia in Alzheimer's Disease Progression | 001 | 2 | NIH | 1/21/2026 | $165,835 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG087387 | Investigating the Role of Adipose Senescent Cells in Cognitive Function and Alzheimer's Disease Progression | 001 | 3 | NIH | 1/21/2026 | $418,175 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DE033455 | TRPM2-mediated immune activation initiates radiation-induced loss of oral function | 000 | 2 | NIH | 3/27/2026 | $622,744 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | F30AI176699 | Macrophage NR4A nuclear receptors in tuberculosis pathogenesis | 000 | 3 | NIH | 1/2/2026 | $39,094 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01HD113693 | Functional Genomics Across an Ethnically and Racially Diverse Endometriosis Population | 001 | 4 | NIH | 1/14/2026 | $202,498 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK135179 | Mechanisms and therapeutic potential of blocking the mitochondrial Mg2+ channel Mrs2 in obesity and NAFLD | 000 | 4 | NIH | 12/30/2025 | $524,931 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133463 | Cellular mechanisms of NLRP3 activation by ALCAT1 in diet-induced obesity | 000 | 4 | NIH | 3/9/2026 | $528,581 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | UG3AG090675 | Building Unique Infrastructure for Large-scale Dementia research in French-Speaking Africa (BUILD-FSA) Project | 001 | 2 | NIH | 3/9/2026 | $22,954 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG075703 | Epidemiology of blood pressure responses to perturbations: Correlates and prognosis for vascular risk, end-organ damage, cognitive aging and preclinical Alzheimer's disease | 001 | 5 | NIH | 2/25/2026 | $60,098 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01CA244261 | Mechanistic characterization of the cell cycle-dependent DNA repair pathway- Resubmission | 000 | 7 | NIH | 2/27/2026 | $332,169 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | K01NS126489 | Delineating the role of the gut microbiota and its derived metabolites in the development of dementia in multi-ethnic populations | 000 | 4 | NIH | 2/23/2026 | $220,967 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG018016 | The Mexican Health Aging Study (MHAS) | 002 | 20 | NIH | 2/24/2026 | $98,810 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG081362 | Silencing of astrocytic MAGL as a therapy for Alzheimer’s disease | 000 | 2 | NIH | 3/9/2026 | $771,678 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | $102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 006 | 2 | NIH | 3/2/2026 | -$102,360 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK138035 | Paracrine effects of leptin in regulating visceral fat expansion | 000 | 3 | NIH | 2/25/2026 | $387,500 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | $267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 008 | 2 | NIH | 3/2/2026 | -$267,160 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | $578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 009 | 2 | NIH | 3/2/2026 | -$578,469 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01DK133304 | A novel pathway controls liver injury in NASH | 000 | 5 | NIH | 2/27/2026 | $521,908 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | AY2AX000159 | Rapamycin + Semaglutide To Optimize, Restore, and Extend Healthspan (RSTORE-H) | 000 | 1 | NIH | 2/24/2026 | $11,904,972 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 005 | 2 | NIH | 2/23/2026 | $154,789 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R21AI196999 | Dissecting the role of CD36 on Tbet+ B cells during obesity and autoimmunity | 000 | 1 | NIH | 2/5/2026 | $421,223 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 007 | 2 | NIH | 3/2/2026 | $338,964 |
| | 2026 | 2026 | THE UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO | 7703 FLOYD CURL DR | SAN ANTONIO | TX | 78229-3901 | BEXAR | USA | R01AG059421 | Cognitively Healthy Nonagenarians in the Cross Cohort Collaboration (CCC) | 007 | 2 | NIH | 3/2/2026 | -$338,964 |
|
